Literature DB >> 27459019

Clonal Transmission of Gram-Negative Bacteria with Carbapenemases NDM-1, VIM-1, and OXA-23/72 in a Bulgarian Hospital.

Yvonne Pfeifer1, Angelina Trifonova2, Michael Pietsch1, Magdalena Brunner1, Iva Todorova2, Ivanka Gergova2, Gottfried Wilharm3, Guido Werner1, Encho Savov2.   

Abstract

We characterized 72 isolates with reduced susceptibility to carbapenems (50 Acinetobacter spp., 13 Proteus mirabilis, five Escherichia coli, one Morganella morganii, one Enterobacter cloacae, one Providencia rettgeri, and one Pseudomonas aeruginosa) from a hospital in Sofia, Bulgaria. Different β-lactamase genes were identified by polymerase chain reaction and sequencing. Bacterial strain typing was performed by enzymatic macrorestriction and pulsed-field gel electrophoresis (PFGE) typing as well as multilocus sequence typing for selected isolates. The majority of Acinetobacter baumannii (46/50) and one Acinetobacter pittii isolate harbored carbapenemase genes blaOXA-23 or blaOXA-72; two A. baumannii contained both genes. PFGE typing of all A. baumannii showed the presence of nine different clones belonging to eight sequence types ST350, ST208, ST436, ST437, ST449, ST231, ST502, and ST579. Molecular characterization of the remaining isolates confirmed the presence of one NDM-1-producing E. coli-ST101 clone (five isolates) and one P. mirabilis clone (13 isolates) with VIM-1 and CMY-99. Furthermore, NDM-1 was identified in P. rettgeri and M. morganii and VIM-2 in the P. aeruginosa isolate. The permanent introduction of OXA-23/72 carbapenemase-producing A. baumannii clones into the hospital and the repeated occurrence of one VIM-1-producing P. mirabilis and one NDM-1-producing E. coli-ST101 clone over a period of more than 1 year is of concern and requires intensified investigations.

Entities:  

Keywords:  Acinetobacter baumannii; E. coli; ESBL; Enterobacteriaceae; MLST; multidrug-resistance

Mesh:

Substances:

Year:  2016        PMID: 27459019     DOI: 10.1089/mdr.2016.0059

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  6 in total

1.  Emergence of Carbapenem-Resistant Providencia rettgeri and Providencia stuartii Producing IMP-Type Metallo-β-Lactamase in Japan.

Authors:  Shu Iwata; Tatsuya Tada; Tomomi Hishinuma; Mari Tohya; Satoshi Oshiro; Kyoko Kuwahara-Arai; Miho Ogawa; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

Review 2.  First literature review of carbapenem-resistant Providencia.

Authors:  M Abdallah; A Balshi
Journal:  New Microbes New Infect       Date:  2018-06-04

3.  Acinetobacter baumannii: Epidemiological and Beta-Lactamase Data From Two Tertiary Academic Hospitals in Tshwane, South Africa.

Authors:  Michelle Lowe; Marthie M Ehlers; Farzana Ismail; Gisele Peirano; Piet J Becker; Johann D D Pitout; Marleen M Kock
Journal:  Front Microbiol       Date:  2018-06-12       Impact factor: 5.640

4.  Genome-based characterization of two Colombian clinical Providencia rettgeri isolates co-harboring NDM-1, VIM-2, and other β-lactamases.

Authors:  Adriana Piza-Buitrago; Verónica Rincón; John Donato; Sandra Yamile Saavedra; Carolina Duarte; Jaime Morero; Laurent Falquet; María Teresa Reguero; Emiliano Barreto-Hernández
Journal:  BMC Microbiol       Date:  2020-11-12       Impact factor: 3.605

Review 5.  Genetics of Acquired Antibiotic Resistance Genes in Proteus spp.

Authors:  Delphine Girlich; Rémy A Bonnin; Laurent Dortet; Thierry Naas
Journal:  Front Microbiol       Date:  2020-02-21       Impact factor: 5.640

6.  Whole-Genome-Sequence-Based Characterization of Extensively Drug-Resistant Acinetobacter baumannii Hospital Outbreak.

Authors:  Ghiwa Makke; Ibrahim Bitar; Tamara Salloum; Balig Panossian; Sahar Alousi; Harout Arabaghian; Matej Medvecky; Jaroslav Hrabak; Samar Merheb-Ghoussoub; Sima Tokajian
Journal:  mSphere       Date:  2020-01-15       Impact factor: 4.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.